Vaddi Krishna's Form 4 filing
Prelude Therapeutics Inc (PRLD) · filed Mar 27, 2025
- Accession no.
- 0001562180-25-002778
- Filed
- Mar 27, 2025
- Trade date
- Mar 25, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $465.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vaddi KrishnaCIK 0001824633 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | Common Stock | PPurchaseAcquired | +675,000 | $0.69 | +$465,750 | 1,999,296 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.